Shionogi Forms Comprehensive Partnership to Strengthen Antimicrobial Stewardship in Kenya Shionogi & Co., Ltd. (Head Office: Chuo-ku, Osaka; “Shionogi”) is pleased to announce that it has signed a comprehensive partnership agreement with Nagasaki University (Nagasaki City, Nagasaki), Saraya Co., Ltd.…
GSK Reports Positive Phase III Results for Linerixibat in Treating Itch Associated with PBC GSK plc (LSE/NYSE: GSK) today announced positive results from its GLISTEN phase III trial evaluating linerixibat, an investigational ileal bile acid transporter (IBAT) inhibitor, in adults…
Eli Lilly Announces Executive Leadership Changes to Propel Future Growth Eli Lilly and Company (NYSE: LLY) today announced a series of executive leadership transitions designed to strengthen its ability to deliver sustained, long-term growth and expand access to its medicines…
Otsuka Pharmaceutical Signs Research Agreement with Keio University to Advance Psychedelic Treatment Infrastructure in Japan Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that it has signed a non-clinical (basic research) agreement with Keio University (Keio) to collaborate on developing the…
argenx SE (Euronext & Nasdaq: ARGX), a global immunology company focused on improving the lives of people with severe autoimmune diseases, today announced its financial results for the first quarter of 2025 and provided a comprehensive business update. CEO Statement…
Strong FY2024 Performance and Strategic Outlook for FY2025 The company reported core revenue growth of 7.4% at actual exchange rates (AER) and 2.8% at constant exchange rates (CER) for fiscal year 2024, reflecting solid product performance across key markets. Core…
Gilead Sciences, Inc. (Nasdaq: GILD) today announced new data from multiple analyses which reinforce that Livdelzi® (seladelpar), known as Lyvdelzi® in the European Union, is effective and generally well-tolerated for the treatment of primary biliary cholangitis (PBC) and also provides sustained biochemical…
Novo Nordisk Reports Strong Operating Profit and Sales Growth, Updates 2025 Outlook Novo Nordisk announced a 22% increase in operating profit in Danish kroner, or 20% growth at constant exchange rates (CER), reaching DKK 38.8 billion. Sales in the US…
Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced the launch of its Elecsys® PRO-C3 test, a new diagnostic tool developed in collaboration with Nordic Bioscience, to assess the severity of liver fibrosis in patients with metabolic dysfunction–associated steatotic liver disease…
GSK to Present 43 Abstracts Across Respiratory Portfolio at ATS 2025, Including New Data on Mepolizumab and Depemokimab GSK plc (LSE/NYSE: GSK) today announced that 43 abstracts, including four late-breaking submissions, from its inhaled and respiratory biologics portfolio will be…
Amgen Posts Strong First Quarter 2025 Financial Results, Driven by Robust Product Demand and Strategic Launches Amgen Inc. (NASDAQ: AMGN) reported its financial results for the first quarter of 2025, showcasing solid performance across its global portfolio. The biotechnology giant…
BOTOX® Cosmetic Expands Commitment to Female Empowerment with The Confidence Project for Women Entrepreneurs In a bold move to champion female entrepreneurship and narrow the persistent confidence gap between men and women in business, Allergan Aesthetics, an AbbVie company (NYSE:…